Debio 8609, Sanvar® is synthetic octapeptide analogue of the naturally-occurring somatostatin hormone for the treatment of esophageal variceal bleeding. Sanvar® is used prior to endoscopic intervention to control haemorrhage and prevent re-bleeding during the critical five days following the onset of bleeding.

In November 2008, Debiopharm submitted an NDA (new drug application) with the U.S. Food and Drug Administration for Sanvar®.

Press Releases

Publications